Fast and accurate drug resistance testing

As more ARVs become available throughout the world, managing the threat of drug resistance will continue to be a global priority. ExaVir Drug is on the front line of this effort by providing doctors with a tool they can use to quickly check for resistance and optimize therapy.

ExaVir Drug allows phenotypic drug resistance testing of the virus circulating in a patient's plasma. The information is available in as little as three days, and with only a few hours hands-on laboratory work. The level of susceptibility to a drug is given as an IC50 value and as fold-difference between the patient's virus and a wild type reference. Studies have established its usefulness in detecting susceptibility to Nevirapine and Efavirenz. AZT and d4T are also available for evaluation. The analysis gives a direct answer to the question of which treatment is effective in each individual case

The test can be performed at any laboratory currently using ExaVir Load Version 2. ExaVir Drug is not currently compatible with Version 3 separation equipment. Contact a Cavidi representative for compatibility updates.

ExaVir Drug is a registered CE-marked IVD-product (in vitro diagnostic use).